SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending after reports surfaced of a potential partnership with Novo Nordisk to distribute GLP-1 obesity drugs, signaling an end to their prior legal dispute. This development has ignited fervent community discussion about a massive short squeeze due to the stock's high short interest and its strengthened position in the digital health market.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending following a surprise partnership announcement with Hims & Hers to distribute its obesity drugs, ending a prior feud. The community is actively discussing the substantial surge in Hims' stock compared to Novo Nordisk's more modest reaction, raising questions about the deal's implications for the GLP-1 market and competitive landscape.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community celebrates the imminent departure of a prominent FDA official, widely seen as a significant barrier to the approval of its Duchenne Muscular Dystrophy therapy, Deramiocel. This development, coupled with high anticipation for a late-breaking Phase 3 data presentation at a major medical conference, is fueling intense bullish sentiment and expectations for a rapid regulatory decision.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure (QURE) is experiencing a sharp rebound, driven by the departure of a controversial FDA official, which the community speculates could pave an easier regulatory path for its Huntington's disease gene therapy and is currently fueling a short squeeze.

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.

Savara Inc

Savara is trending following the FDA's Day 74 Letter confirming MOLBREEVI's Biologics License Application is under full review with a PDUFA target action date of August 22, 2026, and no advisory committee meeting planned. The community sees this as a positive step towards Molbreevi becoming a first-in-class therapy for autoimmune PAP, fueling optimism around its market potential and future valuation.

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.

Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals ($DAWN) is trending after agreeing to be acquired by Servier for $21.50 per share in cash, a deal valued at approximately $2.5 billion that offers a significant premium. The community is celebrating substantial gains, with many noting how patience and conviction paid off amidst previous buyout speculation and a recent massive volume spike.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as it announces a $300 million restructuring charge, fueling speculation among investors about a potential exit from its struggling Converse brand. The community remains divided, with many concerned about ongoing margin pressures and the slow pace of a turnaround, while others see a long-term buying opportunity despite confusing price action around recent tariff news.

Rithm Capital Corp. engages in the provision of real estate, credit, and financial services. It operates through the following segments: Origination and Servicing, Investment Portfolio, Residential Transitional Lending, Asset Management, and Corporate. The Origination and Servicing segment includes residential mortgage loans underlying mortgage servicing right assets as well as those sub-service for third parties. The Investment Portfolio segment consists of residential mortgage loans, SFR properties, consumer loans, Non-Agency RMBS, Excess MSRs and servicer advance investments. The Residential Transitional Lending segment competes for both experienced sponsors, including developers and investors in residential real estate, and attractive lending opportunities based on several factors. The Asset Management segment focuses on the wholly owned subsidiaries, Sculptor, and RCM Manager. The company was founded on September 26, 2011 and is headquartered in New York, NY.

Rithm Capital Corporation

Rithm Capital is actively discussed for its impending S&P SmallCap 600 index inclusion, which analysts anticipate will trigger substantial institutional buying, alongside its consistent earnings beats and strategic evolution into a diversified asset manager. The community is vigorously debating the stock's significant undervaluation and the potential for a future C-Corp conversion or spin-off to unlock considerable shareholder value.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is currently trending following strong Q4 earnings and optimistic 2026 revenue guidance, significantly bolstered by a key competitor's recent clinical setback in the Cushing's syndrome market; this fuels community discussions on Recorlev's blockbuster trajectory and XP-8121's Phase 3 progress despite ongoing market volatility.

Global X Funds - Global X Copper Miners ETF

Copper miners are rallying to new highs, fueled by escalating demand from AI, electrification, and defense sectors amidst a deepening structural supply deficit. The community is actively discussing copper as the next major commodity breakout, especially with new US tariffs aiming to bolster strategic critical mineral reserves.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Marathon Digital (NASDAQ:MARA) Trading Down 8.7% - Should You Sell?

Marathon Digital (NASDAQ:MARA) Trading Down 8.7% - Here's What Happened...

Marathon Digital (NASDAQ:MARA) Trading Down 5.6% - Time to Sell?

Marathon Digital (NASDAQ:MARA) Trading Down 5.6% - Here's Why...

<ul><li>Saylor’s comments come amid Bitcoin miners increasingly selling their BTC holdings amid a sector-wide pivot to artificial intelligence and high-performance computing data centers.</li><li>The collective amount of Bitcoin held by miners fell 4.44% month over month in February to around 115,225 BTC.</li><li>In the last three months, Riot Platforms has been the single largest liquidator of Bitcoin among miners, selling 1,818 BTC in December 2025 for around $161.6 million in net proceeds.</li></ul>Executive chairman Michael Saylor said on Wednesday that Strategy's war chest can outmatch any Bitcoin (BTC) seller amid crypto miners increasingly liquidating their holdings.&nbsp;“We can buy more Bitcoin than they can sell,” he&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/saylor/status/2029237484727542226">wrote</a> in a post on X. His comments come as Bitcoin miners like MARA Holdings (MARA), CleanSpark (CLSK), Riot Platforms (RIOT), and Bitdeer Technologies (BTDR) have liquidated some or all of their holdings.<figure class="image"><a class="st-link-external" href="https://x.com/saylor/status/2029237484727542226" target="_blank" rel="noopener noreferrer nofollow"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_03_05_022109_png_0cdaf12df8.webp" alt="Screenshot 2026-03-05 022109.png" width="819" height="196"></a><figcaption>Source: @saylor/X</figcaption></figure><a href="https://stocktwits.com/symbol/MSTR">MSTR’s stock</a> edged 0.20% lower in overnight trade after clocking&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/winklevoss-led-gemi-stock-sees-biggest-gain-since-debut-on-bitcoin-pump/cZdQKgURIdo">double-digit gains</a> during the day after Bitcoin’s price rose to nearly $74,000. Retail sentiment around the Bitcoin proxy rose to ‘bullish’ from ‘neutral’ territory over the past day, and chatter climbed to ‘low’ from ‘extremely low’ levels.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_03_05_022622_png_b1ac12cbbb.webp" alt="Screenshot 2026-03-05 022622.png" width="1359" height="146"><figcaption>MSTR retail sentiment and message volume on March 5 as of 2:55 a.m. ET | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">$7 Billion Bitcoin Holdings At Stake</h2>Crypto miners combined control around $7.4 billion in Bitcoin, according to CryptoRank data. It&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://cryptorank.io/news/feed/c1e32-bitcoin-miners-sold-5359-btc-as-winter-power-costs-bite-and-their-7-4-billion-treasury-starts-shrinking-fast">reported</a> that the collective BTC held by miners fell 4.44% month over month in February to around 115,335 Bitcoin. However, most of these sales did not occur because Bitcoin’s price fell, but because these companies were seeking liquidity to fund their pivot to AI.Core Scientific (CORZ) also&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/core-scientific-plans-to-sell-more-btc-first-quarter/cZdeLGXRIP7">announced</a> this week that it plans to potentially sell all of its Bitcoin holdings in the first quarter (Q1) of 2026. The company said sales would help finance a large build‑out of AI and high‑performance computing (HPC) data centers in 2026.&nbsp;<a href="https://stocktwits.com/symbol/CORZ">CORZ’s stock</a> edged 0.32% higher in overnight trade on Wednesday after a jump of 3.53% in the regular session as crypto stocks&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/winklevoss-led-gemi-stock-sees-biggest-gain-since-debut-on-bitcoin-pump/cZdQKgURIdo">rallied</a> alongside Bitcoin.Meanwhile, Bitdeer Technologies&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-sale-is-not-a-concern-no-plans-to-stop-crypto-mining-says-bitdeer/cZRtkAQR4Uv">announced</a> last month that it had liquidated all of its Bitcoin holdings to fund land acquisition opportunities. In a post on X, the company said that its decision to sell Bitcoin “should not be a concern for the broader market” and added that it plans to keep mining the apex cryptocurrency.&nbsp;<a href="https://stocktwits.com/symbol/BTDR">BTDR’s stock</a> edged 0.38% higher in overnight trade after a jump of 4.63% in the regular session.<h2 class="st-heading-2">Bitcoin Miners Liquidate Holdings&nbsp;</h2>MARA Holdings, the second-largest holder of Bitcoin after Strategy, didn’t say it needs funds for its AI pivot but did&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/mara-sell-bitcoin-amid-one-billion-net-loss/cZdeZAuRIPZ">revise</a> its treasury strategy earlier this week to include the possibility of selling at least a part of its almost $4 billion BTC reserve. In a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/RobSamuelsIR/status/2028879276091817991">post</a> on X, the company said it has only “expanded” its strategy to allow for Bitcoin sales, but does not intend to “sell the majority of its Bitcoin holdings.”<a href="https://stocktwits.com/symbol/MARA/">MARA’s stock</a> fell 1.4% in overnight trade following a pump of 7.27% during the regular session. On Stocktwits, retail sentiment around the company remained in ‘extremely bullish’ territory, amid ‘extremely high’ chatter.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_03_05_030848_png_de02480783.webp" alt="Screenshot 2026-03-05 030848.png" width="1355" height="134"><figcaption>MARA retail sentiment and message volume on March 5 as of 3:05 a.m. ET | Source: Stocktwits</figcaption></figure>In January, CleanSpark said it mined 573 BTC and sold around 159 BTC to fund operations. Over the last three months, Riot Platforms has been the single largest liquidator of Bitcoin among miners, selling 1,818 BTC in December 2025 for around $161.6 million in net proceeds.<a href="https://stocktwits.com/symbol/RIOT/">RIOT’s stock</a> was also trending lower after hours, down 0.91% following a gain of 8.11% in the regular session. Retail sentiment around the company on Stocktwits improved to ‘neutral’ from ‘bearish’ territory over the past day, with chatter at ‘high’ levels.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/dogecoin-ethereum-outperform-bitcoin-after-600-million-liquidation-wave/cZdQWu1RIdV">Dogecoin, Ethereum Outperform Bitcoin After $600 Million Liquidation Wave Hits Crypto Market</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Michael Saylor speaks on stage during Bitcoin Conference 2023 at Miami Beach Convention Center on May 19, 2023 in Miami Beach, Florida. (Photo by Jason Koerner/Getty Images for Bitcoin Magazine)

Michael Saylor Says ‘We Can Buy More Bitcoin Than They Can Sell’ Amid Billions Sold By Miners

Bitcoin, having fallen by more than 40% from its October peak, has led miners like MARA Holdings, CleanSpark, Riot Platforms, and Bitdeer Technologies to liquidate some or all of their holdings.

Cryptocurrency

Marathon Digital (NASDAQ:MARA) Shares Up 7.3% - Time to Buy?

Marathon Digital (NASDAQ:MARA) Stock Price Up 7.3% - Time to Buy...

American Century Companies Inc. Reduces Stock Position in Marathon Digital Holdings, Inc. $MARA

American Century Companies Inc. lessened its holdings in shares of Marathon Digital Holdings, Inc. (NASDAQ:MARA - Free Report) by 31.9% during the third quarter, according to the company in its most...

Marathon Digital (NASDAQ:MARA) Stock Price Down 8.4% - Should You Sell?

Marathon Digital (NASDAQ:MARA) Trading Down 8.4% - Should You Sell...

<ul class="summary-bullets"><li>MARA Holdings revised its 2026 treasury policy on Monday to permit sales of Bitcoin held on its balance sheet.</li><li>The company held 53,822 BTC worth $4.7 billion at the end of last year, with portions loaned and pledged.</li><li>MARA reported a $1.7 billion Q4 net loss, including a $1.5 billion fair-value loss on digital assets.</li></ul>Mara Holdings has joined the list of crypto companies selling Bitcoin as part of a new strategy for 2026.&nbsp;The revision expanded beyond the company’s prior approach of holding mined Bitcoin as a long-term investment and only permitting sales from mining production in 2025. According to the&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.mara.com/sec-filings/all-sec-filings/content/0001507605-26-000007/mara-20251231.htm">filing</a>, MARA may continue to hold Bitcoin for long-term investment purposes, and it may also buy or sell Bitcoin from time to time, subject to market conditions and capital allocation priorities.<a href="https://stocktwits.com/symbol/MARA/sentiment">Mara Holdings (MARA)</a> was down by over 5% as of Tuesday morning. On Stocktwits, the retail sentiment around MARA remained in the ‘extremely bullish territory,’ as chatter levels around it remained ‘extremely high’ over the past day.&nbsp;<h2 class="st-heading-2">Treasury Holdings And Q4 Results</h2>MARA held 53,822 BTC worth approximately $4.7 billion at the end of the previous year. About 28% of those holdings were activated under its digital asset management strategy, including 9,377 Bitcoin (BTC) loaned to counterparties and 5,938 BTC pledged as collateral against $350 million in outstanding credit facilities. The loaned Bitcoin generated $32.1 million in interest income during the year.In its fourth-quarter&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.quiverquant.com/news/MARA+Holdings+Inc.+%28MARA%29+Releases+Q4+2025+Earnings%3A+Steep+Loss%2C+Revenue+and+EPS+Mis">earnings</a> report, MARA reported a net loss of $1.7 billion, primarily driven by a $1.5 billion loss from changes in the fair value of digital assets. Revenue totaled $202.3 million, down 5.63% year-over-year and below the consensus estimate of $262.0 million. The firm reported&nbsp;a loss per share of $4.52.<h2 class="st-heading-2">Fair Value Of Bitcoin Holdings</h2>MARA recorded a $422.2 million decrease in the fair value of its Bitcoin holdings during 2025. A separately managed account funded with 2,000 BTC incurred a net trading loss of $22.1 million before being terminated in December. Including fair-value adjustments, the trading segment recorded a total loss of $69.1 million for the year.MARA mined 8,799 BTC in 2025, compared with 9,430 BTC in the prior year, and ended the year with an energized hashrate of 66.4 EH/s.MARA’s policy update came as other publicly traded miners also planned Bitcoin sales, as reflected in recent earnings filings. Core Scientific also&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/core-scientific-plans-to-sell-more-btc-first-quarter/cZdeLGXRIP7">announced</a> on Monday in its annual report and fourth-quarter statement that it sold approximately 1,900 Bitcoin in January for about $175 million and expects to sell its remaining holdings in the first quarter of 2026 to enhance liquidity and fund capital expenditures.Read also: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/michael-saylor-says-he-s-buying-bitcoin-right-now-as-strc-offers-over-11-yield/cZdeZhuRIPj">Michael Saylor Says He’s Buying Bitcoin ‘Right Now’ As STRC Offers Over 11% Yield</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, Marathon Digital Holdings logo.  

MARA Plans To Sell Bitcoin Amid $1.7 Billion Q4 Net Loss

MARA Holdings generated $32.1 million in interest income from lending Bitcoin as part of its digital asset strategy over the past year.

Equity

MARA Holdings generated $32.1 million in interest income from lending Bitcoin as part of its digital asset strategy over the past year.


Marathon Digital (NASDAQ:MARA) Trading 5.7% Higher - Here's Why

Marathon Digital (NASDAQ:MARA) Trading 5.7% Higher - What's Next...

Harvest Portfolios Group Inc. Has $4.55 Million Stake in Marathon Digital Holdings, Inc. $MARA

Harvest Portfolios Group Inc. boosted its position in shares of Marathon Digital Holdings, Inc. (NASDAQ:MARA - Free Report) by 86.3% during the 3rd quarter, according to the company in its most...

Marathon Digital (NASDAQ:MARA) Trading Up 5.8% - Still a Buy?

Marathon Digital (NASDAQ:MARA) Shares Up 5.8% - Should You Buy...

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Up 5%+

Up 0–5%

Down 0–5%

Down 5%+

Stocktwits

Stocktwits Polls

Marathon Digital Holdings Inc

Intense investor anger and blame are directed at CEO Fred Thiel, accusing him of poor management, value destruction, and questionable financial decisions.

Traders are frustrated as the stock consistently underperforms Bitcoin's movements, failing to rally significantly when BTC rises but dropping sharply on declines.

Numerous users are predicting further significant price drops for the stock, with many forecasting returns to single-digit lows like $3 or even bankruptcy.

A contingent of bullish traders believes the stock is oversold and heavily shorted, anticipating an imminent short squeeze that could lead to a strong rebound.

MARA
Marathon Digital Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MARA News

MARAMarathon Digital Holdings Inc